« Back
Home /
Human RSV Monoclonal Antibody

Human RSV Monoclonal Antibody

Item no.	YR0070-20mg
Manufacturer	Abclonal
Amount	20 mg
Quantity options	1 mg 20 mg 5 mg
Category	ELISA Immunostaining Functional Assays Neutralization
Applications	ELISA, FA, NT
Specific against	other
Isotype	IgG1 Kappa
Purity	>95% Determined by SDS-PAGE
NCBI	RSV
Alias	Rsvgp08
Available
Manufacturer - Applications	ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways
Manufacturer - Category	Biosimilar
Manufacturer - Conjugate / Tag	<5% Determined by SECP
Storage Conditions	2 - 8°C for up to 4 weeks and -80°C for long term storage (Avoid repeated freezing and thawing)
Background	Palivizumab, a humanized anti-RSV (respiratory syncytial virus) monoclonal antibody, targets an epitope in the A antigenic site of the F protein of RSV, inhibiting its entry into the cell and thereby preventing infection.
Manufacturer - Cross Reactivity	<1EU/mg (<0.001EU/μg)Determined by LAL gel clotting assay
Immunogen	Respiratory Syncytial Virus F protein
Recommended Dilution	In Vivo Grade Recombinant Human IgG1 Kappa Isotype Control Antibody
Route	1×PBS pH 7.0
Manufacturer - Research Area	Cancer immunology
Gene Symbol	RSV

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

YR0070-20mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 20 mg

available

Delivery expected until 12/4/2025

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer